This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at http://www.bbc.co.uk/news/health-34176581
The article has changed 2 times. There is an RSS feed of changes available.
Previous version
1
Next version
Version 0 | Version 1 |
---|---|
Snakebite antidote is running out | Snakebite antidote is running out |
(about 4 hours later) | |
The world is running out of one of the most effective snakebite treatments, putting tens of thousands of lives at risk, warn experts. | The world is running out of one of the most effective snakebite treatments, putting tens of thousands of lives at risk, warn experts. |
Medicins Sans Frontieres says new stocks of Fav-Afrique, which neutralises 10 different snakebites that can occur in Sub-Saharan Africa, are desperately needed. | |
The last batch will expire in June 2016 and there is no comparable replacement. | The last batch will expire in June 2016 and there is no comparable replacement. |
Manufacturer Sanofi Pasteur says it has been priced out of the market. | Manufacturer Sanofi Pasteur says it has been priced out of the market. |
Alternatives are available but MSF says they are not as good. | Alternatives are available but MSF says they are not as good. |
Fav-Afrique is the only anti-venom that has been proven safe and effective to treat envenoming from different types of snakes across Sub-Saharan Africa, it says. | Fav-Afrique is the only anti-venom that has been proven safe and effective to treat envenoming from different types of snakes across Sub-Saharan Africa, it says. |
Sanofi said it will share the anti-venom recipe with others. | Sanofi said it will share the anti-venom recipe with others. |
The company stopped producing the serum last year and has since switched to making a rabies treatment instead. | The company stopped producing the serum last year and has since switched to making a rabies treatment instead. |
Sanofi is believed to be negotiating for another company to produce Fav-Afrique, but these talks are not expected to be finalised before late 2016. This means that a replacement product could not be expected to reach the market for another two years, says MSF. | Sanofi is believed to be negotiating for another company to produce Fav-Afrique, but these talks are not expected to be finalised before late 2016. This means that a replacement product could not be expected to reach the market for another two years, says MSF. |
The absence of a broad, safe and effective anti-venom until then will translate into countless deaths, it says. | The absence of a broad, safe and effective anti-venom until then will translate into countless deaths, it says. |
Lives at risk | Lives at risk |
Polly Markandya of MSF said: "Most people who get bitten by a snake aren't exactly sure what kind of snake it is that bit them and so having an anti-venom that works against a variety of different species is really important. | Polly Markandya of MSF said: "Most people who get bitten by a snake aren't exactly sure what kind of snake it is that bit them and so having an anti-venom that works against a variety of different species is really important. |
"We are worried that without that anti-venom available, people will die unnecessarily." | "We are worried that without that anti-venom available, people will die unnecessarily." |
Alain Bernal, a Sanofi Pasteur spokesman, said the company had offered to transfer the anti-venom technology to others, adding: "Nothing has materialised yet." | Alain Bernal, a Sanofi Pasteur spokesman, said the company had offered to transfer the anti-venom technology to others, adding: "Nothing has materialised yet." |
The World Health Organization says snakebites are a neglected issue that needs more attention and investment. | The World Health Organization says snakebites are a neglected issue that needs more attention and investment. |
Each year, an estimated five million people worldwide are bitten by snakes, out of whom 100,000 die and 400,000 are permanently disabled or disfigured. | Each year, an estimated five million people worldwide are bitten by snakes, out of whom 100,000 die and 400,000 are permanently disabled or disfigured. |
In Sub-Saharan Africa alone, 30,000 people die from snakebite every year and an estimated 8,000 undergo amputations. | In Sub-Saharan Africa alone, 30,000 people die from snakebite every year and an estimated 8,000 undergo amputations. |
Previous version
1
Next version